Anticancer Bioscience is a highly ambitious, emerging, fast-growing and international precision oncology company, led by a management team that has world-class expertise in cancer research, and in innovating genetic tools such as synthetic lethality and in the design of novel high-throughput screening approaches.

As well as access to the scientific expertise of the J. Michael Bishop Institute of Cancer Research, we are advised by leading scientists and clinicians in oncology.

Our commercial expertise is strengthened through the experience of our board.

MANAGEMENT

Dun Yang PhD

Founder, president and CEO, Chengdu

 

Jing Zhang PhD

Co-founder, VP of High Throughput and High Content Screening, Chengdu

 

Thaddeus Allen PhD

VP of Translational Biology and Business Development, San Francisco

 

Hong Liu PhD

VP of Clinical Development, Chengdu and San Francisco

 

Shenqiu Zhang PhD

VP of Medical Statistics and Bioinformatics, St Andrews